Healthcare costs for allergic rhinitis patients on allergy immunotherapy: a retrospective observational study

References

• Long A, McFadden C, DeVine D, et al. Management of Allergic and Nonallergic Rhinitis (Evidence Report/Technology Assessment No. 54 (Prepared by New England Medical Center Evidence-based Practice Center under Contract No. 290-97-0019). AHRQ Pub. No. 02-E024. Rockville (MD): Agency for Healthcare Research and Quality, May 2002
   Google Scholar
• Settipane RA. Demographics and epidemiology of allergic and nonallergic rhinitis. Allergy Asthma Proc 2001;22:185-9
   PubMed Web of Science ®Google Scholar
• Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001;108:S45-S53
   PubMed Web of Science ®Google Scholar
• Seidman MD, Gurgel RK, Lin SY, et al. Clinical practice guideline: allergic rhinitis. Otolaryngol Head Neck Surg 2015;152:S1-43
   PubMed Web of Science ®Google Scholar
• Blaiss MS. Allergic rhinitis: direct and indirect costs. Allergy Asthma Proc 2010;31:375-80
   PubMed Web of Science ®Google Scholar
• Burks AW, Calderon MA, Casale T, et al. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy Clin Immunol 2013;131:1288-96 e3
   Google Scholar
• Eng PA, Borer-Reinhold M, Heijnen IA, Gnehm HP. Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood. Allergy 2006;61:198-201
   PubMed Web of Science ®Google Scholar
• Mosbech H, Osterballe O. Does the effect of immunotherapy last after termination of treatment? Follow-up study in patients with grass pollen rhinitis. Allergy 1988;43:523-9
   PubMed Web of Science ®Google Scholar
• Jacobsen L, Niggemann B, Dreborg S, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007;62:943-8
   PubMed Web of Science ®Google Scholar
• Hankin CS, Cox L, Lang D, et al. Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costs. J Allergy Clin Immunol 2008;121:227-32
   PubMed Web of Science ®Google Scholar
• Hankin CS, Cox L, Bronstone A, Wang Z. Allergy immunotherapy: reduced health care costs in adults and children with allergic rhinitis. J Allergy Clin Immunol 2013;131:1084-91
   PubMed Web of Science ®Google Scholar
• Donahue JG, Greineder DK, Connor-Lacke L, et al. Utilization and cost of immunotherapy for allergic asthma and rhinitis. Ann Allergy Asthma Immunol 1999;82:339-47
   PubMed Web of Science ®Google Scholar
• Creticos PS, Reed CE, Norman PS, et al. Ragweed immunotherapy in adult asthma. N Engl J Med 1996;334:501-6
   PubMed Web of Science ®Google Scholar
• Public law 104-191m 104th Congress. 1996. Available at: https://www.cms.gov/Regulations-and-Guidance/HIPAA-Administrative-Simplification/HIPAAGenInfo/Downloads/HIPAALaw.pdf [Last accessed 18 November 2015]
   Google Scholar
• Cox L, Nelson H, Lockey R, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol 2011;127:S1-S55
   PubMed Web of Science ®Google Scholar
• Blume SW, Yeomans K, Allen-Ramey F, et al. Administration and burden of subcutaneous immunotherapy for allergic rhinitis in U.S. and Canadian clinical practice. J Manag Care Spec Pharm 2015;21:982-90
   PubMed Web of Science ®Google Scholar
• Clinical Classification Software (CCS) for ICD-9-CM. Available at: http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp [Last accessed 30 August 2014]
   Google Scholar
• Quan HLB, Couris CM, Fushimi K, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 2011;173:676-82
   PubMed Web of Science ®Google Scholar
• Austin PC. A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med 2008;27:2037-49
   PubMed Web of Science ®Google Scholar
• US Department of Labor, Bureau of Labor Statistics. Consumer Price Index. Medical care. Series id: CUUR0000SAM. 2013; Available at: http://data.bls.gov/cgi-bin/surveymost?su.
   Google Scholar
• Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 2011;10:150-61
   PubMed Web of Science ®Google Scholar
• Rao JNK, Scott AJ. The analysis of categorical data from complex sample surveys: chi-squared tests for goodness-of-fit and independence in two-way tables. J Am Stat Assoc 1981;76:221-30
   Web of Science ®Google Scholar
• Rao JNK. On simple adjustments to chi-squared tests with survey data. Ann Stat 1987;15:385-97
   Web of Science ®Google Scholar
• Iuga AO, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy 2014;7:35-44
   PubMedGoogle Scholar
• Bender BG, Oppenheimer J. The special challenge of nonadherence with sublingual immunotherapy. J Allergy Clin Immunol Pract 2014;2:152-5
   Web of Science ®Google Scholar
• Cohn JR, Pizzi A. Determinants of patient compliance with allergen immunotherapy. J Allergy Clin Immunol 1993;91:734-7
   PubMed Web of Science ®Google Scholar
• Lower T, Henry J, Mandik L, et al. Compliance with allergen immunotherapy. Ann Allergy 1993;70:480-2
   PubMedGoogle Scholar
• Pajno GB, Vita D, Caminiti L, et al. Children’s compliance with allergen immunotherapy according to administration routes. J Allergy Clin Immunol 2005;116:1380-1
   PubMed Web of Science ®Google Scholar
• Rhodes BJ. Patient dropouts before completion of optimal dose, multiple allergen immunotherapy. Ann Allergy Asthma Immunol 1999;82:281-6
   PubMed Web of Science ®Google Scholar
• Ruiz FJ, Jimenez A, Cocoletzi J, Duran E. [Compliance with and abandonment of immunotherapy]. Rev Alerg Mex 1997;44:42-4
   PubMedGoogle Scholar
• Tinkelman D, Smith F, Cole WQ 3rd, Silk HJ. Compliance with an allergen immunotherapy regime. Ann Allergy Asthma Immunol 1995;74:241-6
   PubMed Web of Science ®Google Scholar
• Vaswani R, Garg A, Parikh L, Vaswani S. Non-adherence to subcutaneous allergen immunotherapy: inadequate health insurance coverage is the leading cause. Ann Allergy Asthma Immunol 2015;115:241-3
   PubMed Web of Science ®Google Scholar
• Senna GCM, Lockey RF. Allergen immunotherapy adherence in the real world: How bad is it and and how can it be improved? Curr Treat Options Allergy 2015;2:39-53
   Google Scholar
• Bender BG. Motivating patient adherence to allergic rhinitis treatments. Curr Allergy Asthma Rep 2015;15:10
   PubMed Web of Science ®Google Scholar
• Kronick R, Gilmer T, Dreyfus T, Lee L. Improving health-based payment for Medicaid beneficiaries: CDPS. Health Care Financ Rev 2000;21:29-64
   PubMed Web of Science ®Google Scholar
• Taylor DH Jr, Fillenbaum GG, Ezell ME. The accuracy of medicare claims data in identifying Alzheimer’s disease. J Clin Epidemiol 2002;55:929-37
   PubMed Web of Science ®Google Scholar
• Zuberbier T, Bachert C, Bousquet PJ, et al. GA(2) LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma. Allergy 2010;65:1525-30
   PubMed Web of Science ®Google Scholar
• Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998;102:558-62
   PubMed Web of Science ®Google Scholar
• Anolik R, Schwartz AM, Sajjan S, Allen-Ramey F. Patient initiation and persistence with allergen immunotherapy. Ann Allergy Asthma Immunol 2014;113:101-7
   PubMed Web of Science ®Google Scholar